MedTrace Logo

Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin

NCT07084116 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-24

No results posted yet for this study

Summary

The purpose of this research is to determine whether once nightly application of tretinoin 0.1% cream to forearm skin reduces the frequency of skin tears and bruising (solar purpura), and changes skin thickness over a period of 6 months.

Conditions

  • Skin Tear
  • Solar Purpura
  • Dermatoporosis

Interventions

DRUG

Tretinoin 0.1% cream

Tretinoin 0.1% cream formulation.

DRUG

Bland cream (non-drug)

Bland cream formulation.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2026-01-01
Completion
2026-02-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07084116 on ClinicalTrials.gov